Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
Lymphoma, Non-Hodgkin
About this trial
This is an observational trial for Lymphoma, Non-Hodgkin focused on measuring Adverse Effects, Burkitt's Lymphoma, Diffuse Large Cell Lymphoma, Extended Remission, Health Status, Lymphoblastic Lymphoma, Molecular Studies
Eligibility Criteria
Patients with a histologic diagnosis of small noncleaved cell (undifferentiated) (SNCL), lymphoblastic (LL), and large cell lymphoma (LCL) who were treated according to National Cancer Institute Pediatric Branch non-Hodgkin's lymphoma protocols 74-0, 75-6, 76-5, 77-04, 85-C-67, and 89-C-41A, and who have been in continuous remission for one year or longer following completion of treatment. Patients who have relapsed and been successfully re-treated are not excluded, except for patients with lymphoblastic lymphoma who have been re-treated according to acute lymphoblastic leukemia protocols.
Sites / Locations
- National Cancer Institute (NCI)